You are here

  • Home
  • Archive
  • Volume 94, Issue 4
  • Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

Article metrics

Article menu
Multiple sclerosis
Original research
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

 

Online download statistics by month:

Online download statistics by month: December 2022 to February 2023

AbstractFullPdf
Dec 2022750743178
Jan 2023889865104
Feb 202364364367
Total22822251349